University of California, San Francisco: Hematologic Neoplasms trials
The registry lists 12 Hematologic Neoplasms studies with University of California, San Francisco as lead sponsor. 1 are open to participants now and 2 have results posted.
Phase 2 2No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Wearable Activity Tracking to Curb HospitalizationsRecruitingNCT06587100
- Donor Lymphocyte Infusion With Azacitidine to Prevent Hematologic Malignancy Relapse After Stem Cell TransplantationCompletedNCT02458235Phase 2Results posted
- A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic MalignanciesCompletedNCT01036009Phase 2Results posted
- Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up CareCompletedNCT05641961Not applicable
- Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and TelehealthCompletedNCT04630015
- Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant PatientsCompletedNCT03609840
- Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant PatientsCompletedNCT03609827
- Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)CompletedNCT03609814
- Study of Fludarabine Drug Exposure in Pediatric Bone Marrow TransplantationCompletedNCT01316549
- Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic MalignanciesTerminatedNCT00514722Not applicable
- Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic MalignanciesTerminatedNCT00513318
- Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic AnemiaCompletedNCT00513175